CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Jennifer Taubert announces retirement from J&J; Takeda's global TYK2 leader exits

Neutral
AI Analysis

Summary

Jennifer Taubert, the worldwide chair of Johnson & Johnson Innovative Medicine, is retiring, with her responsibilities to be transferred to Tom. The article also references a Takeda executive departure related to TYK2 programs.

Importance:2/10
Sentiment:
0.00
executive_changeretirementleadershippersonnel
Related Companies

Read the original article

Published by Endpoints News on August 7, 2026 11:00 AM

Read Original